Abstract:Objective: Comparative genomic hybridization (CGH) is a new molecular and cellular technology developed from fluorescence in situ hybridization (FISH). It is a molecular cytogenetics method used to examine genomic imbalances, especially the deletion and amplification of chromosomes, and to locate these alterations in certain chromosome regions. To completely understand the possible differences in genomic DNA between three paclitaxel-resistant nasopharyngeal carcinoma cell lines (CNE1/Taxol, HNE2/Taxol, 5-8F/Taxol) and corresponding parent cells (CNE1, HNE2, 5-8F) which were sensitive to paclitaxel medication, and the significance of the differences in nasopharyngeal carcinoma acquired drug-resistance, the genomic DNA of three paclitaxel-resistant nasopharyngeal carcinoma cell lines and their parent cell lines were detected and analyzed using comparative genomic hybridization (CGH). Methods: The three paclitaxel-resistant nasopharyngeal carcinoma cell lines (CNE1/Taxol, HNE2/Taxol, 5-8F/Taxol) were created by combining high-dose pulse therapy in the parent cells with stepwise dose increments of paclitaxel. The resistance index was determined by colony formation. Cell CGH was performed on paclitaxel-resistant nasopharyngeal carcinoma cell lines and the parent cell lines to explore the changes in chromosomal DNA regions. Results: The resistance indices of the three paclitaxel-resistant nasopharyngeal carcinoma cell lines (CNE1/Taxol, HNE2/Taxol, 5-8F/Taxol) were 8.43, 8.27 and 5.26, respectively. There were extensive chromosomal changes in the three parent cell lines when compared to normal genomic DNA, mainly seen in the co-amplification of 3q21-qter, 5p13-pter, 12 and 20q11-qter, and the common deletion of 10q11-qter, 18 and X in all three parent cell lines. However, the three paclitaxel-resistant cell lines showed a relatively normal karyotype with changes mainly in the co-amplification of 3q21-qter, 5p13-pter, 12, 20q11-qter and 8q21-qter. Compared with the common amplifications in parent cell lines, a new co-amplification of 8q21-qter was detected in the three paclitaxel-resistant nasopharyngeal carcinoma cell lines. Conclusion: Co-amplification of 3q21-qter, 5p13-pter, 12 and 20q11-qter, and deletion of 10q11-qter, 18, and X may be associated with nasopharyngeal carcinoma. Chromosomal amplification of 8q21-qter may be related to paclitaxel-resistance in nasopharyngeal carcinoma cell lines. Further studies on these chromosome regions may supply new clues on the occurrence of nasopharyngeal carcinoma and the mechanism of acquired resistance of nasopharyngeal carcinoma to paclitaxel.

[Differential expression of taxol resistance and taxol resistance reversal related genes in nasopharyngeal carcinoma by cDNA microarray].

Exploring Specific miRNA-mRNA Axes With Relationship to Taxanes-Resistance in Breast Cancer

Reversal of Taxol Resistance by Cisplatin in Nasopharyngeal Carcinoma by Upregulating Thromspondin-1 Expression

Genomic methylation profiling combined with gene expression microarray reveals the aberrant methylation mechanism involved in nasopharyngeal carcinoma taxol resistance.

Identification of Prognostic Biomarkers for Response to Radiotherapy by DNA Microarray in Nasopharyngeal Carcinoma Patients

Amplification of chromosome 8q21-qter associated with the acquired paclitaxel resistance of nasopharyngeal carcinoma cells

Screening differential expression of docetaxel-resistance related genes of human lung adenocarcinoma cell line SPC-A1 by cDNA microarray

Reversal of Taxol Resistance by Cisplatin in Human Nasopharyngeal Carcinoma Cell Lines

Studies on Comparative Genomic Hybridization between Multiple Types of Paclitaxel-resistant Nasopharyngeal Carcinoma Cells and the Parent Cell Lines

[Role of Folate Receptor 1 in Paclitaxel-Resistance of Nasopharyngeal Carcinoma Cells].

MiR-1204 sensitizes nasopharyngeal carcinoma cells to paclitaxel both in vitro and in vivo.

Gene Expression Profiling of Taxol-Resistant Nasopharyngeal Carcinoma Cells with Sirna-Mediated FOLR 1 Downregulation

Establishment of a paclitaxel-resistant human nasopharyngeal carcinoma cell line and study of its mechanisms

Dna Microarray Reveals Different Pathways Responding To Paclitaxel And Docetaxel In Non-Small Cell Lung Cancer Cell Line

MiR-634 Sensitizes Nasopharyngeal Carcinoma Cells to Paclitaxel and Inhibits Cell Growth Both in Vitro and in Vivo.

Differential Expression and Alternative Splicing of Transcripts Associated with Cisplatin-Induced Chemoresistance in Nasopharyngeal Carcinoma

Establishment of Radioresistant Human Nasopharyngeal Carcinoma Cells and the Differential Gene Expression by Cdna Microarray Analysis

Profiles and Bioinformatics Analysis of Differentially Expressed Circrnas in Taxol-Resistant Non-Small Cell Lung Cancer Cells.

Next Generation Deep Sequencing Identified a Novel Lncrna N375709 Associated with Paclitaxel Resistance in Nasopharyngeal Carcinoma

Microarray Expression Profile of Long Non-Coding RNAs in Paclitaxel-Resistant Human Lung Adenocarcinoma Cells.

Neferine sensitized Taxol-resistant nasopharygeal carcinoma to Taxol by inhibiting EMT via downregulating miR-130b-5p